Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome

No abstract is available for this paper.

• Publication year

  2014

• Venue

  European Journal of Clinical Microbiology and Infectious Diseases

• Publication date

  2014-03-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10096-014-2081-3PMID 24599709
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dysbiosis Signature of Fecal Microbiota in Colorectal Cancer Patients

  2013cited by this paper
• Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.

  2013influential reference
• Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease?

  2013cited by this paper
• Fusobacterium Is Associated with Colorectal Adenomas

  2013cited by this paper
• Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin.

  2013influential reference
• Colorectal cancer: looking for answers in the microbiota.

  2013cited by this paper
• Association of Streptococcus bovis endocarditis and advanced colorectal neoplasia: A case–control study

  2013cited by this paper
• Functional genomic analyses of the gut microbiota for CRC screening

  2013cited by this paper
• Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma.

  2012influential reference
• Gut microbial activity, implications for health and disease: the potential role of metabolite analysis.

  2012cited by this paper
• Genomic analysis identifies association of Fusobacterium with colorectal carcinoma.

  2012influential reference
• A metagenomic insight into our gut's microbiome

  2012cited by this paper
• Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota

  2012cited by this paper
• Mucosal Invasion by Fusobacteria is a Common Feature of Acute Appendicitis in Germany, Russia, and China

  2012cited by this paper
• IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine

  2012cited by this paper
• The microbiota and its metabolites in colonic mucosal health and cancer risk.

  2012cited by this paper
• Panbacterial real-time PCR to evaluate bacterial burden in chronic wounds treated with Cutimed™ Sorbact™

  2011cited by this paper
• Towards the Human Colorectal Cancer Microbiome

  2011cited by this paper
• Human nutrition, the gut microbiome and the immune system

  2011cited by this paper
• Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers

  2011cited by this paper
• Invasive potential of gut mucosa‐derived fusobacterium nucleatum positively correlates with IBD status of the host

  2011cited by this paper
• Fusobacterium nucleatum Infection of Colonic Cells Stimulates MUC2 Mucin and Tumor Necrosis Factor Alpha

  2011cited by this paper
• Enterotypes of the human gut microbiome

  2011influential reference
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• TLR2 sensing of F. nucleatum and S. sanguinis distinctly triggered gingival innate response.

  2009cited by this paper
• Low counts of Faecalibacterium prausnitzii in colitis microbiota

  2009cited by this paper
• Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis.

  2008cited by this paper
• The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects.

  2007cited by this paper
• Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world.

  2006cited by this paper
• Analysis of the Fecal Microbiota of Irritable Bowel Syndrome Patients and Healthy Controls with Real-Time PCR

  2005cited by this paper
• The advanced adenoma as the primary target of screening.

  2002cited by this paper
• Update on the taxonomy and clinical aspects of the genus fusobacterium.

  2002cited by this paper
• Risk factors for advanced colorectal adenomas: a pooled analysis.

  2002cited by this paper
• Mucosa-Associated Bacteria in the Human Gastrointestinal Tract Are Uniformly Distributed along the Colon and Differ from the Community Recovered from Feces

  2002cited by this paper
• Interactions between Periodontal Bacteria and Human Oral Epithelial Cells: Fusobacterium nucleatum Adheres to and Invades Epithelial Cells

  2000cited by this paper
• Fusobacterial infections: an underestimated threat.

  2000cited by this paper
• Association between intraepithelial Escherichia coli and colorectal cancer.

  1998cited by this paper
• High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas.

  1997cited by this paper
• The bacteria of periodontal diseases.

  1994cited by this paper
• [The intrauterine contraceptive device].

  1992cited by this paper
• Aetiology of adenoma--carcinoma sequence in large bowel.

  1978cited by this paper

• Associations of epidemiologic risk factors with Fusobacterium nucleatum and bacterial alpha diversity in the colorectal tumor-associated microbiota

  2026cites this paper
• VERU-111 Promotes an Anti-Tumor Response Through Restoration of Gut Microbial Homeostasis and Associated Metabolic Dysregulation

  2026cites this paper
• Gut microbiota immaturity with DL-endopeptidase deficiency links antibiotic use to preterm late-onset sepsis.

  2026cites this paper
• The impact of the microbiome on colorectal cancer recurrence.

  2026cites this paper
• Targeting Microbiome Metabolites: Reshaping Immunotherapy and Clinical Management Strategies for Colorectal Cancer

  2026cites this paper
• The Role of the Gut Microbiome in Clinical Outcomes of Colorectal Cancer: A Systematic Review (2020-2025).

  2026cites this paper
• Gut microbiota-driven diseases and intervention strategies – lessons from China

  2025cites this paper
• Gut microbiota alterations and their association with tumorigenic pathways in colorectal cancer: insights from a pooled analysis of 109 microbiome datasets

  2025cites this paper
• The effects of different forms of vitamin E on gut microbiota, mechanisms and implications in disease prevention.

  2025cites this paper
• The Role of Cervicovaginal Microbiota and Probiotics in Modulating HPV Persistence and Preventing Cervical Cancer.

  2025cites this paper
• The microbiota in breast cancer: dysbiosis, microbial metabolites, and therapeutic implications.

  2025cites this paper
• Characterization of the gut microbiota in patients with stage III colorectal cancer: A case-control study.

  2025cites this paper
• Gut Microbiota in Colorectal Cancer Carcinogenesis: The Evolution of Hypotheses

  2025cites this paper
• From obesity to cancer: Gut microbiome mechanisms, biomarkers, and U.S. public health strategies

  2025cites this paper
• Fusobacterium nucleatum Enrichment in Colorectal Tumor Tissue: Associations With Tumor Characteristics and Survival Outcomes

  2025cites this paper
• The Gut Microbiome in Early-Onset Colorectal Cancer: Distinct Signatures, Targeted Prevention and Therapeutic Strategies

  2025cites this paper
• Guild-Level Response of the Gut Microbiome to Nutritional Signals: Advancing Precision Nutrition for Metabolic Health.

  2025cites this paper
• The number of teeth is a prognostic indicator for chemotherapy in colorectal cancer.

  2025cites this paper
• Association of Fusobacterium nucleatum with colorectal cancer molecular subtypes and its outcome: a systematic review

  2025cites this paper
• The Role of Bacteria-Derived Hydrogen Sulfide in Multiple Axes of Disease

  2025cites this paper
• FadA antigen of Fusobacterium nucleatum: implications for ceRNA network in colorectal cancer and adenomatous polyps progression

  2025cites this paper
• Fusobacterium nucleatum and Gastric Cancer: An Emerging Connection

  2025cites this paper
• Prognostic impact of Fusobacterium nucleatum on survival in colorectal cancer: A systematic review and meta-analysis.

  2025cites this paper
• The Impact of Fusobacterium nucleatum and the Genotypic Biomarker KRAS on Colorectal Cancer Pathogenesis

  2025cites this paper
• Impact of Fusobacterium nucleatum on immune cell interactions and gene expression in colorectal cancer: a retrospective cohort study

  2025cites this paper
• Targeting Intratumoral Bacteria for Cancer Nanotherapeutics

  2025cites this paper
• The cancer microbiome.

  2025cites this paper
• Highly sensitive DNA testing of Fusobacterium nucleatum (Fn) in colorectal tumors.

  2025cites this paper
• Can Fusobacterium utilize nucleomodulins in the pathophysiology of CRC?

  2025cites this paper
• Antibody responses to 11 Fusobacterium proteins and colorectal cancer-specific and overall survival in the EPIC cohort.

  2025cites this paper
• Interaction of human gut microbiota and local immune system in progression of colorectal adenoma (MIMICA-1): a protocol for a prospective, observational cohort study

  2025cites this paper
• Revisiting berberine for the prevention and treatment of Fusobacterium nucleatum-induced colorectal cancer from a dynamic perspective

  2025cites this paper
• Potential Pathogens Associated with Colorectal Cancer.

  2025cites this paper
• The Microbiome's Role in Driving Anastomotic Leak and Cancer Recurrence Following Colorectal Surgery.

  2025cites this paper
• The Relationship of the Microbiome, Associated Metabolites and the Gut Barrier with Pancreatic Cancer.

  2025cites this paper
• The Oral Microbiome and Cancer.

  2025cites this paper
• Fusobacterium nucleatum: strategies for adapting to aerobic stress

  2025cites this paper
• The rise and evolving role of Fusobacterium nucleatum subspecies

  2025cites this paper
• The Translational Research Program in Cancer Differences across Populations

  2025cites this paper
• Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study

  2025cites this paper
• Infectious Agents and Esophageal Cancer: A Comprehensive Review

  2025cites this paper
• Preoperative metronidazole treatment to evaluate its efficacy in reducing Fusobacterium nucleatum colonisation in colorectal cancer patients: a proof-of-concept trial

  2025cites this paper
• The Causal Role of Gut Microbiota and Immune Cell Mediation in Gastroenteropancreatic Neuroendocrine Neoplasms: A Mendelian Randomization Study

  2025cites this paper
• Effects of high-fiber, high-fruit and high-vegetable, low-fat dietary intervention on the rectal tissue microbiome.

  2025cites this paper
• The gut microbiome is associated with disease‐free survival in stage I–III colorectal cancer patients

  2025cites this paper
• Fusobacterium-associated molecular and immunological alterations in colorectal cancer: Insights from a Norwegian cohort

  2025cites this paper
• Ethanolamine-induced assembly of microcompartments is required for Fusobacterium nucleatum virulence

  2024cites this paper
• KRAS mutation promotes the colonization of Fusobacterium nucleatum in colorectal cancer by down‐regulating SERTAD4

  2024cites this paper
• Periodontal bacteria influence systemic diseases through the gut microbiota

  2024cites this paper
• Reexamining the role of Fusobacterium nucleatum subspecies in clinical and experimental studies

  2024cites this paper
• Personalised medicine based on host genetics and microbiota applied to colorectal cancer.

  2024cites this paper
• Thymol-loaded liposomes effectively induced apoptosis and decreased EGFR expression in colorectal cancer cells

  2024cites this paper
• Fusobacterium nucleatum Abundance is Associated with Cachexia in Colorectal Cancer Patients: The ColoCare Study

  2024cites this paper
• Patients with Colorectal Cancer

  2024cites this paper
• A New Method for Gene Deletion to Investigate Cell Wall Biogenesis in Fusobacterium nucleatum.

  2024cites this paper
• Balancing the Oral–Gut–Brain Axis with Diet

  2024cites this paper
• Disruption of the intestinal clock drives dysbiosis and impaired barrier function in colorectal cancer

  2024cites this paper
• Functional links between the microbiome and the molecular pathways of colorectal carcinogenesis

  2024cites this paper
• Fusobacterium nucleatum: Unraveling its potential role in gastric carcinogenesis

  2024cites this paper
• Association of Antibody Responses to Helicobacter pylori Proteins with Colorectal Adenoma and Colorectal Cancer

  2024cites this paper
• A gut-derived Streptococcus salivarius produces the novel nisin variant designated nisin G and inhibits Fusobacterium nucleatum in a model of the human distal colon microbiome

  2024cites this paper
• Genetics, diet, microbiota, and metabolome: partners in crime for colon carcinogenesis

  2024cites this paper
• Advancements in Understanding and Preventing Obesity-Related Colon Cancer

  2024cites this paper
• Overcoming Microbiome-Acquired Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma

  2024cites this paper
• Elucidating the genotoxicity of Fusobacterium nucleatum-secreted mutagens in colorectal cancer carcinogenesis

  2024cites this paper
• Risk of colorectal cancer and adenoma after an appendectomy: results from three large prospective cohort studies and meta-analysis

  2024cites this paper
• Immunomodulation aspects of gut microbiome-related interventional strategies in colorectal cancer

  2024cites this paper
• Gut Microbiome and colorectal cancer: discovery of bacterial changes with metagenomics application in Turkısh population

  2024cites this paper
• Detection of colorectal‐cancer‐associated bacterial taxa in fecal samples using next‐generation sequencing and 19 newly established qPCR assays

  2024cites this paper
• Circulating Bacterial DNA in Colorectal Cancer Patients: The Potential Role of Fusobacterium nucleatum

  2024cites this paper
• The role of Fusobacterium nucleatum in cancer and its implications for clinical applications.

  2024cites this paper
• Rapid detection of FadA in Fusobacterium nucleatum using the quantitative LAMP colorimetric phenol red method in stool samples from colorectal cancer patients

  2024cites this paper
• Engineering Short Antimicrobial Peptides to Specifically Target Fusobacterium nucleatum in the Mixed Microbial Population.

  2024cites this paper
• Targeting bacterial metabolites in tumor for cancer therapy: An alternative approach for targeting tumor-associated bacteria.

  2024cites this paper
• Metastasis and the Microbiome: The Impact of Bacteria in Disseminated Colorectal Cancer.

  2024cites this paper
• Ectopic colonization by oral bacteria as an emerging theme in health and disease

  2024cites this paper
• Association between Bacteroides fragilis and Fusobacterium nucleatum infection and colorectal cancer in Vietnamese patients.

  2024cites this paper
• Spatial transcriptomic analysis reveals local effects of intratumoral fusobacterial infection on DNA damage and immune signaling in rectal cancer

  2024cites this paper
• Cancer invasion and anaerobic bacteria: new insights into mechanisms

  2024cites this paper
• The Role of the Gut Microbiota in the Development of Colorectal Cancer

  2024cites this paper
• Co-Culture of P. gingivalis and F. nucleatum Synergistically Elevates IL-6 Expression via TLR4 Signaling in Oral Keratinocytes

  2024influential citation
• Effect of Chemotherapy on Fusobacterium nucleatum Abundance in Colorectal Cancer Patients: A Study on Relapsing Patients

  2024cites this paper
• Symbiotic symphony: Understanding host-microbiota dialogues in a spatial context.

  2024cites this paper
• Influence of Intestinal Flora on ICB Therapy for Colorectal Cancer

  2024cites this paper
• Ethanolamine-induced assembly of microcompartments is required for Fusobacterium nucleatum virulence

  2024cites this paper
• Investigation of the Association Between Periodontal Disease Indices, Number of Missing Teeth and Risk of Thyroid Cancer Development: A Case – Control Study

  2024cites this paper
• A Longitudinal Dynamic Change in LMR Can Be a Biomarker for Recurrence in Fusobacterium Nucleatum-Positive Colorectal Cancer Patients

  2024cites this paper
• Microbiota in colorectal cancer related to liver metastasis.

  2024cites this paper
• Enhancing Colorectal Cancer Screening with Droplet Digital PCR (ddPCR) Analysis of Fusobacterium nucleatum in Fecal Immunochemical Test (FIT) Samples.

  2024cites this paper
• Study of Periodontal Bacteria in Diabetic Wistar Rats: Assessing the Anti-Inflammatory Effects of Carvacrol and Magnolol Hydrogels

  2024cites this paper
• Unlocking the secrets: exploring the influence of the aryl hydrocarbon receptor and microbiome on cancer development

  2024cites this paper
• Dysregulation of saliva and fecal microbiota as novel biomarkers of colorectal cancer

  2024cites this paper
• Changes in Intestinal Microbiota and Their Relationship With Patient Characteristics in Colorectal Cancer

  2024cites this paper
• Intratumoral microorganisms in tumors of the digestive system

  2024cites this paper
• The Roles and Interactions of Porphyromonas gingivalis and Fusobacterium nucleatum in Oral and Gastrointestinal Carcinogenesis: A Narrative Review

  2024cites this paper
• The role of microbiomes in gastrointestinal cancers: new insights

  2024cites this paper
• A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche

  2024cites this paper
• Gut microbiome as a treatment in colorectal cancer

  2024cites this paper
• Number of Healthy Teeth Can Predict the Response of Rectal Cancer to Chemoradiotherapy: A Retrospective Study

  2024cites this paper
• Comparative analysis of adhesion virulence protein FadA from gut-associated bacteria of colorectal cancer patients (F. nucleatum) and healthy individuals (E. cloacae)

  2024cites this paper